A note from the NET Research Foundation
on the passing of Aretha Franklin, Queen of Soul
August 16, 2018
Since 2005, the NET Research Foundation has invested more than $20 million dollars in neuroendocrine tumor research. Neuroendocrine tumors are rare and misunderstood. It is an uncommon cancer that is underfunded and under-resourced.
The NET Research Foundation is the leading private funder of NET cancer research and a nonprofit 501(c)(3) organization. The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for neuroendocrine cancer. NETRF awards large-scale, multi-year research grants to leading scientists at renowned research institutions around the world.
Support NETRF to Foster Innovation and Fuel Discovery
This year our progress signals both the hope and promise of our efforts for you, your family and the patients we serve: together we are getting closer to improved treatments and ultimately cures. As we continue on in the fight against NETs, we are counting on your support for our work.
Thank you for your Generous Donation!
Your support enables the NET Research Foundation to make rapid progress toward discovering cures for carcinoid, pancreatic, and related neuroendocrine cancers. Tribute gifts can be made in honor or memory of a loved one.
NETRF Recognized as Top-Tier Charity
NETRF’s strong financial position, transparency, and accountability again earned it a 4-star rating by Charity Navigator, a national evaluator of nonprofits. The 4-star rating indicates the utmost in fiscal responsibility, ethical practices, and governance.
News & Updates
We are saddened to hear of the passing of Aretha Franklin, the Queen of Soul, who died of a pancreatic neuroendocrine tumor (pNET) this morning. She was a legend in the music industry and it is
(Left to Right) NETRF CEO Elyse Gellerman, Kathy Karpus, George Karpus, NETRF Board Chair Dr. Joe Li. We are pleased to announce a $100,000 grant from the Karpus Family Foundation, Rochester, NY. The grant will help
Patients in different areas of the U.S. are reporting difficulties accessing a relatively new nuclear medicine imaging technique known as the Gallium 68 (Ga-68) scan. These reports prompted a member of the NETRF team to take